Software & Developer Tools
Actimed Therapeutics
United Kingdomactimedtherapeutics.com
Actimed Therapeutics is a startup. 1 investor tracked.
Activeseries-a
series-a
Stage
3
Investors
About Actimed Therapeutics
Actimed Therapeutics is a startup based in the United Kingdom. Its most recent tracked round is Series A. Brouky classifies it under Software & Developer Tools. Brouky records 3 investors associated with the company.
Actimed Therapeutics is a clinical-stage biopharmaceutical company focused on developing treatments for cachexia and other muscle wasting disorders. Its lead product, S-pindolol benzoate (ACM-001.1), targets multiple pathways that drive cachexia and has generated promising proof of concept Phase II clinical data in cachexia patients.
Explore Actimed Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.